Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma.
Labrinidis A, Diamond P, Martin S, Hay S, Liapis V, Zinonos I, Sims NA, Atkins GJ, Vincent C, Ponomarev V, Findlay DM, Zannettino AC, Evdokiou A.
Labrinidis A, et al. Among authors: zinonos i.
Clin Cancer Res. 2009 Mar 15;15(6):1998-2009. doi: 10.1158/1078-0432.CCR-08-2444. Epub 2009 Mar 10.
Clin Cancer Res. 2009.
PMID: 19276263
Free PMC article.